Adial Pharmaceuticals has completed a pharmacokinetics study of its investigational drug AD04, aimed at treating Alcohol Use Disorder (AUD) in patients with a specific genomic biomarker. The results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results